SIMG
TWST icon

Stephens Investment Management Group’s Twist Bioscience TWST Stock Holding History

Stephens Investment Management Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.9M Buy
+767,364
New +$49.9M 0.85% 50

Other funds holding TWST

New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Stephens Investment Management Group's TWST Position: Q2 2026 in Review

Stephens Investment Management Group opened a new position in Twist Bioscience (TWST) in Q2 2026: 767,364 shares worth $78.9M. The stake represents 0.85% of the portfolio and ranks #50 among its holdings.

63 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Stephens Investment Management Group held 767,364 shares of Twist Bioscience worth $78.9M as of Q2 2026.
  • Twist Bioscience was a new Stephens Investment Management Group position in Q2 2026.
  • Twist Bioscience made up 0.85% of Stephens Investment Management Group's portfolio in Q2 2026, its #50 holding.
  • 63 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Stephens Investment Management Group's 13F filing for Q2 2026, filed 29 Jul 2026.